Header Logo
Last Name

Qing Guo

InstitutionUniversity of Oklahoma Health Sciences Center
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R01DK079057     (GUO, QING)Apr 1, 2008 - Jan 31, 2013
    AATF and Renal Protection
    Role: Principal Investigator

    R01NS043296     (GUO, QING)Dec 1, 2002 - Nov 30, 2008
    Regulation of APP Processing by Par-4
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Shiwany NA, Xie J, Guo Q. Cortical neurons transgenic for human Abeta40 or Abeta42 have similar vulnerability to apoptosis despite their different amyloidogenic properties. Int J Clin Exp Pathol. 2009; 2(4):339-52. PMID: 19158991.
      View in: PubMed
    2. Guo Q. When good Cdk5 turns bad. Sci Aging Knowledge Environ. 2006 Feb 08; 2006(5):pe5. PMID: 16469730.
      View in: PubMed
    3. Guo Q. Cyclin-dependent kinase 5--a neuronal killer? Sci Aging Knowledge Environ. 2003 Dec 17; 2003(50):pe36. PMID: 14681576.
      View in: PubMed
    4. Guo Q, Xie J. AATF inhibits aberrant production of amyloid beta peptide 1-42 by interacting directly with Par-4. J Biol Chem. 2004 Feb 06; 279(6):4596-603. PMID: 14627703.
      View in: PubMed
    Guo's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Similar People Expand Description
    Same Department Expand Description